Selected research
Industry Research
Oncology API Industry Research Report 2026
Market perspective
The global Oncology API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Oncology API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Oncology API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Oncology API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Oncology API include Fresenius Kabi Oncology, Suanfarma, Sterling, Shivalik Rasayan, PROCOS SPA, PolyPeptide, Olon Group, Neopharma and Natco, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Oncology API market in terms of revenue (US$ million) and, where applicable, sales volume (K G), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K G) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Oncology API Market by Company
Fresenius Kabi Oncology
Suanfarma
Sterling
Shivalik Rasayan
PROCOS SPA
PolyPeptide
Olon Group
Neopharma
Natco
Kekule Pharma
Hetero
GLS Pharma
Glenmark Life Sciences
Eisai Pharmaceuticals
Dr. Reddy's
CordenPharma
Concord Biotech
Biocon
Bachem
Aspen API
Aenova
Oncology API Segment by Type
Alkylating Agents
Antimetabolites
Others
Oncology API Segment by Application
Immunotherapy
Chemotherapy
Targeted Therapy
Others
Oncology API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncology API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oncology API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncology API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Oncology API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Oncology API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Oncology API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Alkylating Agents
- Antimetabolites
- Others
Applications
- Immunotherapy
- Chemotherapy
- Targeted Therapy
- Others
Companies covered
- Fresenius Kabi Oncology
- Suanfarma
- Sterling
- Shivalik Rasayan
- PROCOS SPA
- PolyPeptide
- Olon Group
- Neopharma
- Natco
- Kekule Pharma
- Hetero
- GLS Pharma
- Glenmark Life Sciences
- Eisai Pharmaceuticals
- Dr. Reddy's
- CordenPharma
- Concord Biotech
- Biocon
- Bachem
- Aspen API
- Aenova
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Oncology API Market Size (2021-2032)
- 2.2.2 Global Oncology API Sales (2021-2032)
- 2.2.3 Global Oncology API Market Average Price (2021-2032)
- 2.3 Oncology API by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Alkylating Agents
- 2.3.3 Antimetabolites
- 2.3.4 Others
- 2.4 Oncology API by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Immunotherapy
- 2.4.3 Chemotherapy
- 2.4.4 Targeted Therapy
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Oncology API Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Oncology API Sales (K G) of Manufacturers (2021-2026)
- 3.3 Global Oncology API Revenue of Manufacturers (2021-2026)
- 3.4 Global Oncology API Average Price by Manufacturers (2021-2026)
- 3.5 Global Oncology API Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Oncology API, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Oncology API, Product Type & Application
- 3.8 Global Manufacturers of Oncology API, Established Date
- 3.9 Global Oncology API Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Fresenius Kabi Oncology
- 4.1.1 Fresenius Kabi Oncology Company Information
- 4.1.2 Fresenius Kabi Oncology Business Overview
- 4.1.3 Fresenius Kabi Oncology Oncology API Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Fresenius Kabi Oncology Oncology API Product Portfolio
- 4.1.5 Fresenius Kabi Oncology Recent Developments
- 4.2 Suanfarma
- 4.2.1 Suanfarma Company Information
- 4.2.2 Suanfarma Business Overview
- 4.2.3 Suanfarma Oncology API Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Suanfarma Oncology API Product Portfolio
- 4.2.5 Suanfarma Recent Developments
- 4.3 Sterling
- 4.3.1 Sterling Company Information
- 4.3.2 Sterling Business Overview
- 4.3.3 Sterling Oncology API Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sterling Oncology API Product Portfolio
- 4.3.5 Sterling Recent Developments
- 4.4 Shivalik Rasayan
- 4.4.1 Shivalik Rasayan Company Information
- 4.4.2 Shivalik Rasayan Business Overview
- 4.4.3 Shivalik Rasayan Oncology API Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Shivalik Rasayan Oncology API Product Portfolio
- 4.4.5 Shivalik Rasayan Recent Developments
- 4.5 PROCOS SPA
- 4.5.1 PROCOS SPA Company Information
- 4.5.2 PROCOS SPA Business Overview
- 4.5.3 PROCOS SPA Oncology API Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 PROCOS SPA Oncology API Product Portfolio
- 4.5.5 PROCOS SPA Recent Developments
- 4.6 PolyPeptide
- 4.6.1 PolyPeptide Company Information
- 4.6.2 PolyPeptide Business Overview
- 4.6.3 PolyPeptide Oncology API Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 PolyPeptide Oncology API Product Portfolio
- 4.6.5 PolyPeptide Recent Developments
- 4.7 Olon Group
- 4.7.1 Olon Group Company Information
- 4.7.2 Olon Group Business Overview
- 4.7.3 Olon Group Oncology API Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Olon Group Oncology API Product Portfolio
- 4.7.5 Olon Group Recent Developments
- 4.8 Neopharma
- 4.8.1 Neopharma Company Information
- 4.8.2 Neopharma Business Overview
- 4.8.3 Neopharma Oncology API Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Neopharma Oncology API Product Portfolio
- 4.8.5 Neopharma Recent Developments
- 4.9 Natco
- 4.9.1 Natco Company Information
- 4.9.2 Natco Business Overview
- 4.9.3 Natco Oncology API Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Natco Oncology API Product Portfolio
- 4.9.5 Natco Recent Developments
- 4.10 Kekule Pharma
- 4.10.1 Kekule Pharma Company Information
- 4.10.2 Kekule Pharma Business Overview
- 4.10.3 Kekule Pharma Oncology API Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Kekule Pharma Oncology API Product Portfolio
- 4.10.5 Kekule Pharma Recent Developments
- 4.11 Hetero
- 4.11.1 Hetero Company Information
- 4.11.2 Hetero Business Overview
- 4.11.3 Hetero Oncology API Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Hetero Oncology API Product Portfolio
- 4.11.5 Hetero Recent Developments
- 4.12 GLS Pharma
- 4.12.1 GLS Pharma Company Information
- 4.12.2 GLS Pharma Business Overview
- 4.12.3 GLS Pharma Oncology API Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 GLS Pharma Oncology API Product Portfolio
- 4.12.5 GLS Pharma Recent Developments
- 4.13 Glenmark Life Sciences
- 4.13.1 Glenmark Life Sciences Company Information
- 4.13.2 Glenmark Life Sciences Business Overview
- 4.13.3 Glenmark Life Sciences Oncology API Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Glenmark Life Sciences Oncology API Product Portfolio
- 4.13.5 Glenmark Life Sciences Recent Developments
- 4.14 Eisai Pharmaceuticals
- 4.14.1 Eisai Pharmaceuticals Company Information
- 4.14.2 Eisai Pharmaceuticals Business Overview
- 4.14.3 Eisai Pharmaceuticals Oncology API Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Eisai Pharmaceuticals Oncology API Product Portfolio
- 4.14.5 Eisai Pharmaceuticals Recent Developments
- 4.15 Dr. Reddy's
- 4.15.1 Dr. Reddy's Company Information
- 4.15.2 Dr. Reddy's Business Overview
- 4.15.3 Dr. Reddy's Oncology API Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Dr. Reddy's Oncology API Product Portfolio
- 4.15.5 Dr. Reddy's Recent Developments
- 4.16 CordenPharma
- 4.16.1 CordenPharma Company Information
- 4.16.2 CordenPharma Business Overview
- 4.16.3 CordenPharma Oncology API Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 CordenPharma Oncology API Product Portfolio
- 4.16.5 CordenPharma Recent Developments
- 4.17 Concord Biotech
- 4.17.1 Concord Biotech Company Information
- 4.17.2 Concord Biotech Business Overview
- 4.17.3 Concord Biotech Oncology API Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Concord Biotech Oncology API Product Portfolio
- 4.17.5 Concord Biotech Recent Developments
- 4.18 Biocon
- 4.18.1 Biocon Company Information
- 4.18.2 Biocon Business Overview
- 4.18.3 Biocon Oncology API Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Biocon Oncology API Product Portfolio
- 4.18.5 Biocon Recent Developments
- 4.19 Bachem
- 4.19.1 Bachem Company Information
- 4.19.2 Bachem Business Overview
- 4.19.3 Bachem Oncology API Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Bachem Oncology API Product Portfolio
- 4.19.5 Bachem Recent Developments
- 4.20 Aspen API
- 4.20.1 Aspen API Company Information
- 4.20.2 Aspen API Business Overview
- 4.20.3 Aspen API Oncology API Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 Aspen API Oncology API Product Portfolio
- 4.20.5 Aspen API Recent Developments
- 4.21 Aenova
- 4.21.1 Aenova Company Information
- 4.21.2 Aenova Business Overview
- 4.21.3 Aenova Oncology API Sales, Revenue and Gross Margin (2021-2026)
- 4.21.4 Aenova Oncology API Product Portfolio
- 4.21.5 Aenova Recent Developments
5 Global Oncology API Market Scenario by Region
- 5.1 Global Oncology API Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Oncology API Sales by Region: 2021-2032
- 5.2.1 Global Oncology API Sales by Region: 2021-2026
- 5.2.2 Global Oncology API Sales by Region: 2027-2032
- 5.3 Global Oncology API Revenue by Region: 2021-2032
- 5.3.1 Global Oncology API Revenue by Region: 2021-2026
- 5.3.2 Global Oncology API Revenue by Region: 2027-2032
- 5.4 North America Oncology API Market Facts & Figures by Country
- 5.4.1 North America Oncology API Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Oncology API Sales by Country (2021-2032)
- 5.4.3 North America Oncology API Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Oncology API Market Facts & Figures by Country
- 5.5.1 Europe Oncology API Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Oncology API Sales by Country (2021-2032)
- 5.5.3 Europe Oncology API Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Oncology API Market Facts & Figures by Country
- 5.6.1 Asia Pacific Oncology API Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Oncology API Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Oncology API Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Oncology API Market Facts & Figures by Country
- 5.7.1 South America Oncology API Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Oncology API Sales by Country (2021-2032)
- 5.7.3 South America Oncology API Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Oncology API Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Oncology API Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Oncology API Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Oncology API Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Oncology API Sales by Type (2021-2032)
- 6.1.1 Global Oncology API Sales by Type (2021-2032) & (K G)
- 6.1.2 Global Oncology API Sales Market Share by Type (2021-2032)
- 6.2 Global Oncology API Revenue by Type (2021-2032)
- 6.2.1 Global Oncology API Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Oncology API Revenue Market Share by Type (2021-2032)
- 6.3 Global Oncology API Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Oncology API Sales by Application (2021-2032)
- 7.1.1 Global Oncology API Sales by Application (2021-2032) & (K G)
- 7.1.2 Global Oncology API Sales Market Share by Application (2021-2032)
- 7.2 Global Oncology API Revenue by Application (2021-2032)
- 7.2.1 Global Oncology API Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Oncology API Revenue Market Share by Application (2021-2032)
- 7.3 Global Oncology API Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Oncology API Value Chain Analysis
- 8.1.1 Oncology API Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Oncology API Production Mode & Process
- 8.2 Oncology API Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Oncology API Distributors
- 8.2.3 Oncology API Customers
9 Global Oncology API Analyzing Market Dynamics
- 9.1 Oncology API Industry Trends
- 9.2 Oncology API Industry Drivers
- 9.3 Oncology API Industry Opportunities and Challenges
- 9.4 Oncology API Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst